Friday 6 November 2026
Export TAK’s income statement to Excel — free account
Takeda Pharmaceutical Co.
TAK Healthcare Drug Manufacturers Specialty & Generic
Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.
- Revenue
- +1.71%
- EPS
- −4.35%
- Free cash flow
- +54.9%
- Total debt
- −7.28%
Quarter to September 2026, against a year earlier
21.25
0.19
+0.90%
Follow TAK
Alert me
| Sep '26 | Jun '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 6 | — | — |
+8 more TTM periods Free account |
| 0.00% | 4.42% | 0.00% | 0.00% | ||
| 0.00% | 2.15% | 0.00% | 0.00% | ||
ROIC |
0.00% | 2.88% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 13.40% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 73.31 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 2.35 | 0.00 | 0.00 | |
Free Cash Flow |
7,976.47 | 7,420.86 | 10,878.22 | 8,314.41 | |
Capital Expenditures |
(3,579.71) | (3,704.87) | (4,954.63) | (3,167.12) | |
| Other line items | |||||
Cash ROIC |
10.17% | 9.04% | 12.62% | 9.77% | |
Accounts Receivable Turnover |
0.00 | 5.52 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 3.50 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 1.18 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 100.31 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 324.95 | 0.00 | 0.00 | |
Tax Rate |
— | (0.17) | — | — | |
Research and Development Expense of Revenue |
— | 14.77% | — | — | |
Selling, General and Administrative Expense of Revenue |
— | 23.99% | — | — | |
Share Based Compensation of Revenue |
0.00% | 2.33% | 0.00% | 0.00% | |
Interest Coverage |
— | 1.99 | — | — | |
Operating CF/Net income |
0.00 | 5.21 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.48 | 0.53 | 0.73 | 0.56 | |
Capex/Depreciation |
(0.52) | (0.52) | (0.50) | (0.42) | |
Revenue per Share |
— | 9.49 | — | — | |
Operating CF per Share |
0.00 | 3.52 | 0.00 | 0.00 | |
Capex per Share |
0.00 | (1.17) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.12 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026